Literature DB >> 20622904

Biomarkers of immune activation to screen for severe, acute GVHD.

K J August1, K-Y Chiang, R M Bostick, W D Flanders, E K Waller, A Langston, D Worthington-White, P Rowland, K F Moore, H J Khoury, J T Horan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20622904     DOI： 10.1038/bmt.2010.165

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

Review 1.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

Review 2.  The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.

Authors:  Alaa M Ali; John F DiPersio; Mark A Schroeder
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-05       Impact factor: 5.742

Review 3.  Graft-versus-host disease biomarkers: omics and personalized medicine.

Authors:  Sophie Paczesny; Nisha Raiker; Sam Brooks; Christy Mumaw
Journal:  Int J Hematol       Date:  2013-09       Impact factor: 2.490

4.  A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.

Authors:  Maria Cuzzola; Maurizio Fiasché; Pasquale Iacopino; Giuseppe Messina; Massimo Martino; Giuseppe Console; Roberta Fedele; Daniela Massi; Anna Grazia Recchia; Giuseppe Irrera; Fortunato Morabito
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

5.  Extracellular vesicles as potential biomarkers of acute graft-vs-host disease.

Authors:  G Lia; L Brunello; S Bruno; A Carpanetto; P Omedè; M Festuccia; L Tosti; E Maffini; L Giaccone; M Arpinati; G Ciccone; M Boccadoro; A Evangelista; G Camussi; B Bruno
Journal:  Leukemia       Date:  2017-08-30       Impact factor: 11.528

Review 6.  Advances in predicting acute GVHD.

Authors:  Andrew C Harris; James L M Ferrara; John E Levine
Journal:  Br J Haematol       Date:  2012-12-04       Impact factor: 6.998

7.  MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.

Authors:  Wei Sang; Cong Zhang; Dianzheng Zhang; Ying Wang; Cai Sun; Mingshan Niu; Xiaoshen Sun; Cui Zhou; Lingyu Zeng; Bin Pan; Wei Chen; Dongmei Yan; Feng Zhu; Qingyun Wu; Jiang Cao; Kai Zhao; Chong Chen; Zhenyu Li; Depeng Li; Thomas P Loughran; Kailin Xu
Journal:  Am J Hematol       Date:  2015-10-08       Impact factor: 10.047

Review 8.  Opportunities and challenges of proteomics in pediatric patients: circulating biomarkers after hematopoietic stem cell transplantation as a successful example.

Authors:  Sophie Paczesny; Christine Duncan; David Jacobsohn; Robert Krance; Kathryn Leung; Paul Carpenter; Catherine Bollard; Jamie Renbarger; Kenneth Cooke
Journal:  Proteomics Clin Appl       Date:  2014-10-30       Impact factor: 3.494

9.  Inflammatory Cytokine Profile in Individuals with Inherited Chromosomally Integrated Human Herpesvirus 6.

Authors:  Daniel P Weschke; Wendy M Leisenring; Richard L Lawler; Terry Stevens-Ayers; Meei-Li Huang; Keith R Jerome; Danielle M Zerr; John A Hansen; Michael Boeckh; Joshua A Hill
Journal:  Biol Blood Marrow Transplant       Date:  2019-10-31       Impact factor: 5.742

10.  Soluble interleukin-2 receptor index predicts the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors.

Authors:  Yukinori Nakamura; Yoshinori Tanaka; Mayumi Tanaka; Akiko Sugiyama; Kaoru Yamamoto; Yoshihiro Tokunaga; Toshiaki Yujiri; Yukio Tanizawa
Journal:  Int J Hematol       Date:  2016-01-20       Impact factor: 2.319
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.